Skip to Content
The Illinois-based biopharmaceutical firm is off to a good start in 2020, thanks in part to record sales of the world’s best-selling drug, Humira, which can be used to treat a wide range of ailments including arthritis and Crohn's disease. While the growth of biosimilar drugs threatens its Humira franchise in the long term, AbbVie is nurturing other potential blockbusters, including plaque-psoriasis therapy Skyrizi. The company also received FDA approval to acquire Botox-maker Allergan, which will provide a booster shot to revenue. AbbVie noted the pandemic has reduced prescriptions as a result of a decline in doctor’s office visits, but said it expects this trend to reverse in coming months.
Courtesy of AbbVie
Lists ranking AbbVie
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
RANK15
World’s 25 Best Workplaces - 2020Companies on this year's list earned national reco...READ MOREview in list
RANK67
75 Best Large Workplaces for Women - 2020The companies on this year's list make a conscious...READ MOREview in list
RANK378
Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list
RANK43
75 Best Large Workplaces for Millennials - 2020We surveyed tens of thousands of young employees t...READ MOREview in list
RANK99
Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MOREview in list
RANK3
10 Best Workplaces in Biotechnology and Pharmaceuticals - 2020The best workplaces in healthcare and biopharma ma...READ MOREview in list